These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 27352955)

  • 1. Correlates of Medication Adherence in the TODAY Cohort of Youth With Type 2 Diabetes.
    Katz LL; Anderson BJ; McKay SV; Izquierdo R; Casey TL; Higgins LA; Wauters A; Hirst K; Nadeau KJ;
    Diabetes Care; 2016 Nov; 39(11):1956-1962. PubMed ID: 27352955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to multiple medications in the TODAY (Treatment Options for type 2 Diabetes in Adolescents and Youth) cohort: effect of additional medications on adherence to primary diabetes medication.
    Shah R; McKay SV; Levitt Katz LE; El Ghormli L; Anderson BJ; Casey TL; Higgins L; Izquierdo R; Wauters AD; Chang N;
    J Pediatr Endocrinol Metab; 2020 Feb; 33(2):191-198. PubMed ID: 31809265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postintervention Effects of Varying Treatment Arms on Glycemic Failure and β-Cell Function in the TODAY Trial.
    TODAY Study Group
    Diabetes Care; 2021 Jan; 44(1):75-80. PubMed ID: 33290248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin monotherapy in youth with recent onset type 2 diabetes: experience from the prerandomization run-in phase of the TODAY study.
    Laffel L; Chang N; Grey M; Hale D; Higgins L; Hirst K; Izquierdo R; Larkin M; Macha C; Pham T; Wauters A; Weinstock RS;
    Pediatr Diabetes; 2012 Aug; 13(5):369-75. PubMed ID: 22369102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive and Lipid-Lowering Medication Adherence in Young Adults With Youth-Onset Type 2 Diabetes.
    Weinstock RS; Trief PM; Burke BK; Wen H; Liu X; Kalichman S; Anderson BJ; Bulger JD
    JAMA Netw Open; 2023 Oct; 6(10):e2336964. PubMed ID: 37792373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of patient education on KAP, medication adherence and therapeutic outcomes of metformin versus insulin therapy in patients with gestational diabetes: A Hospital based pilot study in South India.
    Krishnakumar S; Govindarajulu Y; Vishwanath U; Nagasubramanian VR; Palani T
    Diabetes Metab Syndr; 2020; 14(5):1379-1383. PubMed ID: 32755838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HbA1c After a Short Period of Monotherapy With Metformin Identifies Durable Glycemic Control Among Adolescents With Type 2 Diabetes.
    Zeitler P; Hirst K; Copeland KC; El Ghormli L; Levitt Katz L; Levitsky LL; Linder B; McGuigan P; White NH; Wilfley D;
    Diabetes Care; 2015 Dec; 38(12):2285-92. PubMed ID: 26537182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of glycemic control in youth with type 2 diabetes at randomization in the TODAY study.
    Bacha F; Pyle L; Nadeau K; Cuttler L; Goland R; Haymond M; Levitsky L; Lynch J; Weinstock RS; White NH; Caprio S; Arslanian S;
    Pediatr Diabetes; 2012 Aug; 13(5):376-83. PubMed ID: 22332798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of metformin, metformin plus rosiglitazone, and metformin plus lifestyle on insulin sensitivity and β-cell function in TODAY.
    TODAY Study Group
    Diabetes Care; 2013 Jun; 36(6):1749-57. PubMed ID: 23704674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
    Freemark M; Bursey D
    Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth Hormone Mediators and Glycemic Control in Youths With Type 2 Diabetes: A Secondary Analysis of a Randomized Clinical Trial.
    Lu C; Wolfs D; El Ghormli L; Levitsky LL; Levitt Katz LE; Laffel LM; Patti ME; Isganaitis E
    JAMA Netw Open; 2024 Feb; 7(2):e240447. PubMed ID: 38421647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A clinical trial to maintain glycemic control in youth with type 2 diabetes.
    ; Zeitler P; Hirst K; Pyle L; Linder B; Copeland K; Arslanian S; Cuttler L; Nathan DM; Tollefsen S; Wilfley D; Kaufman F
    N Engl J Med; 2012 Jun; 366(24):2247-56. PubMed ID: 22540912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of acarbose versus glibenclamide on glycemic excursion and oxidative stress in type 2 diabetic patients inadequately controlled by metformin: a 24-week, randomized, open-label, parallel-group comparison.
    Wang JS; Lin SD; Lee WJ; Su SL; Lee IT; Tu ST; Tseng YH; Lin SY; Sheu WH
    Clin Ther; 2011 Dec; 33(12):1932-42. PubMed ID: 22078152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
    Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
    Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin Sensitivity and Diabetic Kidney Disease in Children and Adolescents With Type 2 Diabetes: An Observational Analysis of Data From the TODAY Clinical Trial.
    Bjornstad P; Nehus E; El Ghormli L; Bacha F; Libman IM; McKay S; Willi SM; Laffel L; Arslanian S; Nadeau KJ;
    Am J Kidney Dis; 2018 Jan; 71(1):65-74. PubMed ID: 29157731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of response to insulin therapy in youth with poorly-controlled type 2 diabetes in the TODAY trial.
    Bacha F; El Ghormli L; Arslanian S; Zeitler P; Laffel LM; Levitt Katz LE; Gandica R; Chang NT; Sprague JE; Macleish SA;
    Pediatr Diabetes; 2019 Nov; 20(7):871-879. PubMed ID: 31418516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Surgical and Medical Therapy for Type 2 Diabetes in Severely Obese Adolescents.
    Inge TH; Laffel LM; Jenkins TM; Marcus MD; Leibel NI; Brandt ML; Haymond M; Urbina EM; Dolan LM; Zeitler PS;
    JAMA Pediatr; 2018 May; 172(5):452-460. PubMed ID: 29532078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effects of glimepiride or rosiglitazone in combination with metformin on blood pressure control in type 2 diabetic patients affected by the metabolic syndrome: a 12-month, double-blind, randomized clinical trial.
    Derosa G; Cicero AF; Gaddi AV; Ciccarelli L; Piccinni MN; Salvadeo S; Pricolo F; Fogari E; Ghelfi M; Ferrari I; Fogari R
    Clin Ther; 2005 Sep; 27(9):1383-91. PubMed ID: 16291411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychosocial factors predict medication adherence in young adults with youth-onset type 2 diabetes: Longitudinal results from the TODAY2 iCount study.
    Trief PM; Uschner D; Kalichman S; Anderson BJ; Fette LM; Wen H; Bulger JD; Weinstock RS
    Diabet Med; 2023 May; 40(5):e15062. PubMed ID: 36751994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between baseline characteristics and clinical outcomes in a large population of diabetes patients treated with liraglutide in a real-world setting in Italy.
    Lapolla A; Frison V; Bettio M; Dal Pos M; Rocchini P; Panebianco G; Tadiotto F; Da Tos V; D'Ambrosio M; Marangoni A; Ferrari M; Pianta A; Balzano S; Confortin L; Lamonica M; Marin N; Strazzabosco M; Brun E; Mesturino CA; Simoncini M; Zen F; Bax G; Bonsembiante B; Cardone C; Dal Frà MG; Gallo A; Masin M; Piarulli F; Sartore G; Simioni N
    Clin Ther; 2015 Mar; 37(3):574-84. PubMed ID: 25626486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.